dc.contributor | Viramontes-Hörner, D., Departamento de Disciplinas Filosófico Metodológico e Instrumentales, Centro Universitario de Ciencias de la Salud, Universidad de GuadalajaraGuadalajara, Mexico; Márquez-Sandoval, F., CA-UDG-454 Alimentación y nutrición en el proceso salud-enfermedad, Departamento de Reproducción Humana, Crecimiento y Desarrollo Infantil, Centro Universitario de Ciencias de la Salud, Universidad de GuadalajaraGuadalajara, Mexico; Martín-del-Campo, F., Departamento de Disciplinas Filosófico Metodológico e Instrumentales, Centro Universitario de Ciencias de la Salud, Universidad de GuadalajaraGuadalajara, Mexico; Vizmanos-Lamotte, B., CA-UDG-454 Alimentación y nutrición en el proceso salud-enfermedad, Departamento de Reproducción Humana, Crecimiento y Desarrollo Infantil, Centro Universitario de Ciencias de la Salud, Universidad de GuadalajaraGuadalajara, Mexico; Sandoval-Rodríguez, A., Departamento de Biología Molecular y Genómica, Instituto de Biología Molecular y Terapia Génica, Universidad de GuadalajaraGuadalajara, Mexico; Armendáriz-Borunda, J., Departamento de Biología Molecular y Genómica, Instituto de Biología Molecular y Terapia Génica, Universidad de GuadalajaraGuadalajara, Mexico; García-Bejarano, H., Departamento de Nefrología, Hospital General de OccidenteZapopan, Mexico; Renoirte-López, K., División de Nefrología, O.P.D. Hospital Civil de Guadalajara Fray Antonio AlcaldeGuadalajara, Mexico; García-García, G., División de Nefrología, O.P.D. Hospital Civil de Guadalajara Fray Antonio AlcaldeGuadalajara, Mexico | |
dc.description.abstract | Objective: The study aimed to assess the effect of a symbiotic gel on presence and severity of gastrointestinal symptoms (GIS) in hemodialysis patients. Design: A double-blinded, placebo-controlled, randomized, clinical trial was designed. The study was conducted at 2 public hospitals in Guadalajara, Mexico. Subjects and Intervention: Twenty-two patients were randomized to the intervention group (nutritional counseling+symbiotic gel) and 20 patients were randomized to the control group (nutritional counseling+placebo), during 2months of follow-up. Main Outcome Measure: Presence and monthly episodes of GIS were assessed by direct interview and severity by using the self-administered GIS questionnaire. Additionally, biochemical parameters, inflammatory markers, and nutritional status (dietary intake, subjective global assessment, anthropometry, and body composition) were evaluated. Results: After a 2-month treatment, intervention group had a significant reduction in prevalence and monthly episodes of vomit, heartburn, and stomachache, as well as a significant decrease in GIS severity compared with control group. Moreover, intervention group had a greater yet not significant decrease in the prevalence of malnutrition and a trend to reduce their C-reactive protein and tumor necrosis factor α levels compared with control group. No symbiotic-related adverse side effects were shown in these patients. Clinical studies with longer follow-up and sample size are needed to confirm these results. Conclusions: We concluded that administration of a symbiotic gel is a safe and simple way to improve common GIS in dialysis patients. © 2015 National Kidney Foundation, Inc. | |